Need Help?

Evaluating potential drug candidates for the treament of Henamgiopericytoma on patient derived cell line models

Solitary fibrous tumor/Hemangiopericytoma (SFT/HPC) is a rare subtype of soft tissue sarcoma associated with NAB2-STAT6 gene fusions. This study established and characterized a novel SFT/HPC patient-derived cell line called SFT-S1. Potential drug candidates that could be repurposed for the treatment of SFT/HPC were screened. Screening was performed through RNA-Seq

Request Access

Studies are experimental investigations of a particular phenomenon, e.g., case-control studies on a particular trait or cancer research projects reporting matching cancer normal genomes from patients.

Study ID Study Title Study Type
EGAS50000000027 RNASeq

This table displays only public information pertaining to the files in the dataset. If you wish to access this dataset, please submit a request. If you already have access to these data files, please consult the download documentation.

ID File Type Size Located in
EGAF50000048381 fastq.gz 1.0 GB
EGAF50000048384 fastq.gz 1.1 GB
EGAF50000048385 fastq.gz 1.1 GB
EGAF50000048386 fastq.gz 1.1 GB
EGAF50000048387 fastq.gz 1.1 GB
EGAF50000048389 fastq.gz 1.1 GB
EGAF50000048390 fastq.gz 1.1 GB
EGAF50000048391 fastq.gz 1.2 GB
EGAF50000048392 fastq.gz 1.1 GB
EGAF50000048393 fastq.gz 1.1 GB
EGAF50000048394 fastq.gz 1.0 GB
EGAF50000048395 fastq.gz 1.0 GB
EGAF50000048396 fastq.gz 831.8 MB
EGAF50000048397 fastq.gz 860.5 MB
EGAF50000048398 fastq.gz 1.1 GB
EGAF50000048399 fastq.gz 1.1 GB
EGAF50000048400 fastq.gz 791.5 MB
EGAF50000048401 fastq.gz 824.3 MB
18 Files (18.6 GB)